Literature DB >> 32342597

Plasma rich in growth factors reduces blue light-induced oxidative damage on retinal pigment epithelial cells and restores their homeostasis by modulating vascular endothelial growth factor and pigment epithelium-derived factor expression.

Eduardo Anitua1,2, Maria de la Fuente1,2, Susana Del Olmo-Aguado3,4, Carlota Suarez-Barrio3, Jesus Merayo-Lloves3,4, Francisco Muruzabal1,2.   

Abstract

BACKGROUND: This study analysed the effectiveness of plasma rich in growth factors (PRGF) in reducing the oxidative stress induced by blue light exposition on retinal pigment epithelial (RPE) cells.
METHODS: Blood from six healthy donors was collected to obtain the PRGF. Retinal pigment epithelium (ARPE-19) cells were exposed to blue light. Then, cells were incubated with PRGF or with control for 24 and 48 hours maintaining exposure to blue light. The cytoprotective effect of PRGF on ARPE cells was evaluated by measuring the cell viability, the reactive oxygen species (ROS) production and the expression of different proteins such as heme oxygenase 1 (HO-1), catalase (CAT), superoxide dismutase (SOD-1), apoptosis-inducing factor (AIF), pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF).
RESULTS: The cell viability increased significantly at 24 and 48 hours after PRGF treatment compared to the control group. ROS synthesis was significantly reduced in PRGF-treated cells with respect to control. Furthermore, the levels of HO-1, SOD-1 and AIF were significantly reduced after PRGF treatment at both times of treatment. However, CAT levels were only significantly reduced after PRGF treatment at 48 hours. The high expression of VEGF by RPE cells exposed to blue light was only counterbalanced in the PRGF group by increasing the expression of PEDF in comparison to the control group.
CONCLUSION: The present results show that PRGF treatment reduces the cytotoxic effects induced in RPE cells exposed to an oxidative stress environment. Furthermore, PRGF treatment preserves the mitochondrial activity and cell viability of RPE cells subjected to an oxidative stress.
© 2020 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  AMD; PRGF; oxidative stress; platelet-rich plasma; retinal pigment epithelial cell

Year:  2020        PMID: 32342597     DOI: 10.1111/ceo.13767

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  5 in total

1.  Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum.

Authors:  Eduardo Anitua; Francisco Muruzabal; Ander Pino; Roberto Prado; Mikel Azkargorta; Felix Elortza; Jesús Merayo-Lloves
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

2.  An Autologous Topical Serum Derived from Platelet-Rich Plasma Therapy for the Management of Sensitive Skin Alterations: A Case Series Report.

Authors:  Cristina García-Millan; Ander Pino; Rita Rodrigues; Gonzalo Segurado-Miravalles; Adrián Alegre-Sánchez; Pedro Jaén; Eduardo Anitua
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-29

3.  Plasma Rich in Growth Factors Enhances Cell Survival after in Situ Retinal Degeneration.

Authors:  Carlota Suárez-Barrio; Susana Del Olmo-Aguado; Eva García-Pérez; Enol Artime; María de la Fuente; Francisco Muruzabal; Eduardo Anitua; Begoña Baamonde-Arbaiza; Luis Fernández-Vega; Jesús Merayo-Lloves
Journal:  Int J Mol Sci       Date:  2020-10-09       Impact factor: 5.923

4.  Plasma Rich in Growth Factors Promotes Autophagy in ARPE19 Cells in Response to Oxidative Stress Induced by Blue Light.

Authors:  Carlota Suárez-Barrio; Susana Del Olmo-Aguado; Eva García-Pérez; Luis Fernández-Vega-Cueto; Andrés Fernández-Vega Cueto; Begoña Baamonde-Arbaiza; Luis Fernández-Vega; Jesús Merayo-Lloves
Journal:  Biomolecules       Date:  2021-06-28

5.  Lotus Seedpod Proanthocyanidins Protect Against Light-Induced Retinal Damage via Antioxidative Stress, Anti-Apoptosis, and Neuroprotective Effects.

Authors:  Jianmei Wang; Tao Yu; Liuqing Sheng; Hui Zhang; Fei Chen; Jie Zhu; Mingxing Ding
Journal:  Med Sci Monit       Date:  2021-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.